KOREA WHO
-
-
-
CEO of Eubiologics
Baik Yeong-ok
18 Years of Vaccine Development at CJ CheilJedang, Dedicated to Creating 'Premium Vaccines'
-
Last Updated on Nov 22, 2024
-
CEO of Eubiologics
Life Summary
Baik Yeong-ok is the CEO of Eubiologics.
He was born on September 9, 1962.
Baik graduated from Seoul National University with a master’s degree in Veterinary Microbiology and earned a doctorate in Biotechnology from Korea University.
He began his career at Green Cross Veterinary Products Research Center and later worked at CJ CheilJedang’s Pharmaceutical Business Division for 18 years, focusing on vaccine development. During his tenure at CJ CheilJedang, he held positions such as Head of Technology, Head of Production, and Head of Quality Assurance (QA).
Afterward, he served as Head of the Bioprocess Division at the Korea Institute of Industrial Technology.
As plans for establishing the biotech company Eubiologics took shape, Baik Yeong-ok, recognized for his expertise, was brought on as a specialist to manage the company. His contributions to the company’s founding earned him the role of CEO in 2012, a position he has held ever since.
Baik views vaccines as the "flower of life sciences." Under his leadership, Eubiologics has grown into a company poised to surpass KRW 100 billion (approximately USD 72.1 million) in annual revenue by 2024.
#BaikYeongok #Eubiologics #biotechnology #vaccine #lifesciences #KoreaUniversity #SeoulNationalUniversity #CJCheilJedang #leadership #biotechindustry
He was born on September 9, 1962.
Baik graduated from Seoul National University with a master’s degree in Veterinary Microbiology and earned a doctorate in Biotechnology from Korea University.
He began his career at Green Cross Veterinary Products Research Center and later worked at CJ CheilJedang’s Pharmaceutical Business Division for 18 years, focusing on vaccine development. During his tenure at CJ CheilJedang, he held positions such as Head of Technology, Head of Production, and Head of Quality Assurance (QA).
Afterward, he served as Head of the Bioprocess Division at the Korea Institute of Industrial Technology.
As plans for establishing the biotech company Eubiologics took shape, Baik Yeong-ok, recognized for his expertise, was brought on as a specialist to manage the company. His contributions to the company’s founding earned him the role of CEO in 2012, a position he has held ever since.
Baik views vaccines as the "flower of life sciences." Under his leadership, Eubiologics has grown into a company poised to surpass KRW 100 billion (approximately USD 72.1 million) in annual revenue by 2024.
#BaikYeongok #Eubiologics #biotechnology #vaccine #lifesciences #KoreaUniversity #SeoulNationalUniversity #CJCheilJedang #leadership #biotechindustry